Related Experiment Video

Updated: Aug 13, 2026

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
06:44

Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography

Published on: April 13, 2018

Myocardial infarction and deep venous thrombosis in a young patient with Behçet disease

Meral Calgüneri1, Kudret Aydemir, M Akif Oztürk

  • 1Rheumatology, Hacettepe University School of Medicine, Ankara, Turkey.

Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
|January 31, 2006
PubMed

Insights

Behçet disease, a rare cause of heart attack, involves coronary arterial thrombosis and deep venous thrombosis. This case highlights the prothrombotic state in Behçet disease, emphasizing its impact on vascular health.

Area of Science:

  • Cardiology
  • Rheumatology
  • Hematology

Background:

  • Behçet disease (BD) is a chronic systemic vasculitis characterized by relapsing inflammatory episodes.
  • Vascular manifestations in BD typically involve occlusive lesions, suggesting a prothrombotic state.
  • Coronary artery involvement is an uncommon but serious complication of Behçet disease.

Observation:

  • A 27-year-old male presented with myocardial infarction.
  • The patient also exhibited deep venous thrombosis.
  • Coronary arterial thrombosis was identified as the cause of myocardial infarction.

Findings:

  • This case illustrates a rare presentation of Behçet disease with concurrent coronary arterial thrombosis and deep venous thrombosis.
  • Pathologic hemostasis and the hypercoagulable state are key features contributing to thrombotic events in BD.
  • The findings underscore the potential for severe cardiovascular complications in patients with Behçet disease.

Implications:

  • Early recognition and management of thrombotic risk are crucial in Behçet disease patients.
  • Understanding the prothrombotic mechanisms in BD can inform therapeutic strategies.
  • This case highlights the importance of considering Behçet disease in young patients presenting with unexplained thrombosis.

More Related Videos

Venous Thrombosis Assay in a Mouse Model of Cancer04:40

Venous Thrombosis Assay in a Mouse Model of Cancer

Published on: January 5, 2024

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...